noc-18 and Glioblastoma

noc-18 has been researched along with Glioblastoma* in 2 studies

Other Studies

2 other study(ies) available for noc-18 and Glioblastoma

ArticleYear
Induction of PD-L1 by Nitric Oxide via JNK Activation in A172 Glioblastoma Cells.
    Biological & pharmaceutical bulletin, 2020, Jun-01, Volume: 43, Issue:6

    Glioblastoma comprises 54% of all the gliomas derived from glial cells and are lethally malignant tumors of the central nervous system (CNS). Glioma cells disrupt the blood-brain barrier, leading to access of circulating immune cells to the CNS. Blocking the interaction between programmed cell death 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1) enhances T-cell responses against tumor cells, and inhibition of the PD-1/PD-L1 pathway is used as immunotherapy for cancer, including glioblastoma. Nitric oxide (NO) has multiple physiological roles, such as immune modulation and neural transmission in the CNS. Moreover, it has both tumor-promoting and tumor-suppressive functions. We examined the effects of NOC-18, an NO donor, on the expression of PD-L1 in A172 glioblastoma cells. NOC-18 increased PD-L1 expression in A172 glioblastoma cells. Moreover, this increase is regulated via the c-Jun N-terminal kinase pathway.

    Topics: B7-H1 Antigen; Cell Line, Tumor; Central Nervous System Neoplasms; Glioblastoma; Humans; JNK Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds

2020
Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:11

    Mutations in the gene coding for the ubiquitous, anti-oxidant enzyme Cu,Zn superoxide dismutase (SOD1) are associated with familial amyotrophic lateral sclerosis (fALS), a fatal disease characterized by selective loss of motor neurons. Expression of a mutant SOD1 typical of fALS patients restricted to either motor neurons or astrocytes is insufficient to generate a pathological phenotype in mouse models, suggesting that a deleterious interplay between different cell types is necessary for the pathogenesis of the disease. In this study, we demonstrate the actual role of a functional cross-talk between glial and neuronal cells expressing fALS mutant G93A-SOD1, where an increase in the production of reactive oxygen species occurs. We show that human glioblastoma cells expressing G93A-SOD1 induce activation of caspase-1, release of cytokines, and activation of apoptotic pathways in cocultured human neuroblastoma cells also expressing G93A-SOD1. Activation of caspase-1 and caspase-3 is observed also in neuroblastoma lines expressing other fALS-SOD1s (G37R, G85R, and I113T) cocultured with glioblastoma lines expressing the corresponding mutant enzymes. These effects are consequent to activation of inflammatory processes in G93A-glioblastoma cells stimulated by cocultured G93A-neuroblastoma. Furthermore, selective death of embryonal spinal motor neurons from G93A-SOD1 transgenic mice is induced by coculture with G93A-glioblastoma and prevented by inhibition of NO synthase. Proinflammatory cytokines, interferon-gamma, and nitric oxide are among the molecular signals exchanged between glial and neuronal cells that generate a functional interplay between the two cell types. This cross-talk may be crucial for the pathogenesis of SOD1-linked fALS but also for the more common sporadic form of the disease, where markers of increased oxidative stress and of glial activation have been found.

    Topics: Animals; Apoptosis; Caspase 1; Catalase; Cell Communication; Coculture Techniques; Cytokines; Enzyme Activation; Enzyme Inhibitors; Glioblastoma; Humans; Interferon-gamma; Lipopolysaccharides; Mice; Mice, Transgenic; Motor Neuron Disease; Motor Neurons; Neuroblastoma; Neuroglia; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroso Compounds; Oxidative Stress; Reactive Oxygen Species; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Transfection

2004